How Much Evidence do we have on the Central Effects of Botulinum Toxin in Spasticity and Dystonia?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33160717" target="_blank" >RIV/61989592:15110/16:33160717 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.5772/64763" target="_blank" >http://dx.doi.org/10.5772/64763</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.5772/64763" target="_blank" >10.5772/64763</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
How Much Evidence do we have on the Central Effects of Botulinum Toxin in Spasticity and Dystonia?
Popis výsledku v původním jazyce
Abstract The brain is continually reorganizing (plasticity). Plastic changes within the sensorimotor system are not only beneficial (adaptive plasticity) but may even worsen function (maladaptive plasticity). Conditions such as dystonia and poststroke spasticity (PSS) that interfere with motor performance could be attributed to maladaptive plasticity. Botulinum toxin (BoNT) has been proven to be safe and effective in treating various hyperfunctional cholinergic states. Beside the well-known neuromuscular junction site of action, BoNT also exerts effects through supraspinal mechanisms and can even affect cortical reorganization. The hypothesis of central reorganization following BoNT treatment has been supported by studies using neurophysiological and imaging methods in patients with focal dystonia and PSS. The growing evidence of BoNT-related central (remote) effects make BoNT injections a promising tool to favorably affect maladaptive changes even at the cortical level.
Název v anglickém jazyce
How Much Evidence do we have on the Central Effects of Botulinum Toxin in Spasticity and Dystonia?
Popis výsledku anglicky
Abstract The brain is continually reorganizing (plasticity). Plastic changes within the sensorimotor system are not only beneficial (adaptive plasticity) but may even worsen function (maladaptive plasticity). Conditions such as dystonia and poststroke spasticity (PSS) that interfere with motor performance could be attributed to maladaptive plasticity. Botulinum toxin (BoNT) has been proven to be safe and effective in treating various hyperfunctional cholinergic states. Beside the well-known neuromuscular junction site of action, BoNT also exerts effects through supraspinal mechanisms and can even affect cortical reorganization. The hypothesis of central reorganization following BoNT treatment has been supported by studies using neurophysiological and imaging methods in patients with focal dystonia and PSS. The growing evidence of BoNT-related central (remote) effects make BoNT injections a promising tool to favorably affect maladaptive changes even at the cortical level.
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
FH - Neurologie, neurochirurgie, neurovědy
OECD FORD obor
—
Návaznosti výsledku
Projekt
<a href="/cs/project/NV15-31921A" target="_blank" >NV15-31921A: Prevalence spasticity v populaci pacientů postižených ischemickým iktem v karotickém povodí</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Botulinum Toxin Therapy Manual for Dystonia and Spasticity
ISBN
978-953-51-2852-6
Počet stran výsledku
9
Strana od-do
—
Počet stran knihy
180
Název nakladatele
IN TECH d.o.o.
Místo vydání
Rijeka
Kód UT WoS kapitoly
—